Ads
related to: medications contraindicated in sickle cell- Request A Representative
Fill Out The Online Form To Be
Contacted About LYFGENIA.
- Support & Resources
Support For Your Patients During
Their Consideration & Treatment.
- Find A QTC
Use The Qualified Treatment Center
Locator To Find One Nearest You.
- Safety Information
Review Information On Adverse
Reactions & Additional Safety Data.
- Request A Representative
Search results
Results from the WOW.Com Content Network
Crizanlizumab, sold under the brand name Adakveo among others, is a monoclonal antibody medication that binds to P-selectin. [3] It is a medication used to reduce the frequency of vaso-occlusive crisis in people aged 16 years and older who have sickle cell anemia. [3] [4] [6] It is given by injection into a vein. [3] [4]
Hydroxycarbamide, also known as hydroxyurea, is an antimetabolite medication used in sickle-cell disease, essential thrombocythemia, chronic myelogenous leukemia, polycythemia vera, and cervical cancer. [4] [5] In sickle-cell disease it increases fetal hemoglobin and decreases the number of attacks. [4] It is taken by mouth. [4]
Lovotibeglogene autotemcel, sold under the brand name Lyfgenia, is a lentiviral gene therapy used for the treatment of sickle cell disease. [1] [3] [4] [5]The most common side effects include stomatitis (mouth sores of the lips, mouth, and throat), low levels of platelets, white blood cells, and red blood cells, and febrile neutropenia (fever and low white blood cell count), consistent with ...
The Food and Drug Administration says there’s an unmet need for help for patients suffering from severe sickle cell anemia. A new drug that uses gene editing could solve that.
For example, people with sickle cell anemia are contraindicated to RBV therapy and are therefore contraindicated to simeprevir and peg-IFN combination therapy. [13] Pregnant women and men whose female partners are pregnant are contraindicated for simeprevir since peg-IFN and RBV are known to cause birth defects. [11] [13] [14]
Pfizer bought Oxbryta, also known as voxelotor, as part of its $5.4 billion buyout of Global Blood Therapeutics in 2022. Pfizer is also discontinuing all studies and access programs related to the ...
A vaso-occlusive crisis is a common painful complication of sickle cell anemia in adolescents and adults. [1] [2] It is a form of sickle cell crisis.Sickle cell anemia – most common in those of African, Hispanic, and Mediterranean origin – leads to sickle cell crisis when the circulation of blood vessels is obstructed by sickled red blood cells, causing ischemic injuries.
Prilocaine may also be contraindicated in people with sickle cell anemia, anemia, or symptomatic hypoxia. [2] Combinations. ... Drug Information Portal. U.S. National ...
Ads
related to: medications contraindicated in sickle cell